Necrotizing Fasciitis: A Rare Disease with Fatal Consequences
June 4th 2016A recent report describing the development of “flesh-eating bacteria” in a Louisiana woman has the public concerned. The infection developed after the woman injured her foot, resulting in bleeding, while surf fishing in the Gulf of Mexico earlier this May.
Zika Threat Prompts Health Experts to Urge WHO to Move Rio 2016 Games
June 3rd 2016In an open letter copied to the International Olympic Committee, 150 health experts from around the world urged the WHO Director-General, Margaret Chan, MD, MPH, to either postpone or move both the Olympic and Paralympic Games, for the sake of public health.
Zika Virus Vaccine Development Stalled by Concerns Over Marketability
June 3rd 2016Efforts to bring to market a vaccine for the fight against Zika virus, at least via the private sector, have been stalled over concerns regarding the “marketability” of these products, according to multiple reports in the business press.
New Vaccine Development Strategy for Leishmaniasis Shows Promise
June 3rd 2016Management of visceral leishmaniasis poses a daunting challenge, in part due to the side effects associated with the use of the traditional treatment. However, one vaccine development strategy has recently shown promising results.
Thousands in India Claimed to be Infected with HIV through Blood Transfusions
June 2nd 2016A recently published article in an Indian newspaper claims that thousands of civilians living across the country have contracted HIV through blood transfusions, in less than two years; however, a national AIDS organization is refuting these claims.
Zika-Related Microcephaly Case Confirmed at New Jersey Hospital
June 2nd 2016In an attempt to provide the best possible care for her unborn child, a Honduras woman with suspected Zika infection traveled to the United States where she then gave birth to a baby with microcephaly at Hackensack University Medical Center.
Ledipasvir-Sofosbuvir for 8 Weeks: Effective and Cost-effective Against HCV
June 1st 2016A recent study in treatment-naïve patients with chronic hepatitis C virus (HCV) infection has shown that ledipasvir/sofosbuvir (LDV/SOF) combination therapy produces similar sustained virologic response (SVR) rates in clinical trial-based studies and real-world studies.
Influenza Vaccine During Pregnancy May Protect Newborn Infants
May 31st 2016The number of expecting mothers who opt for annual vaccination for influenza during pregnancy remains relatively low; however, the results of a new study suggest this may be changing—and that there are obvious benefits for immunization for newborns.
CDC Releases Updated Guidelines on HIV Nonoccupational Post-Exposure Prophylaxis
May 27th 2016The Centers for Disease Control and Prevention (CDC) has released updated guidelines for the use of nonoccupational post-exposure prophylaxis (nPEP) in persons in the United States, after exposure to human immunodeficiency virus (HIV) outside the health care setting.
Global Influenza Surveillance Program Shows Promising Results
May 27th 2016A program designed to improve the quality of influenza surveillance capabilities in 39 countries from around the globe through partnership with the Centers for Disease Control and Prevention (CDC) seems to have resulted in remarkable progress on all six of the assessed metrics, and even led to improvements in the surveillance of other pathogens, according to the results of a recent study.
Challenging the Gold Standard for Evaluating Influenza Vaccines
May 26th 2016The level of hemagglutination inhibition (HAI) used as the traditional gold standard for evaluating influenza vaccines in the United States and European Union may not actually be the best predictor of protection from influenza virus-induced disease.
African Meningitis Epidemic Would Have Serious Global Repercussions
May 26th 2016Although virtually eradicated in some parts of the developed world, spinal meningitis remains a significant healthcare challenge in the so-called “African meningitis belt,” a region of 26 countries that stretches from Senegal to Ethiopia.
Carbapenem-resistant Enterobacteriaceae (CRE) May Soon Be Treatable
May 25th 2016Researchers from the department of pathology at the Beth Israel Deaconess Medical Center in Boston developed and validated a high-throughput screen (HTS) that could detect antimicrobial agents with the ability to restore carbapenem susceptibility to resistant strains, as well as those that target CRE directly.
A Look into Advanced Molecular Tools Used by the CDC to Advance Public Health
May 24th 2016Cutting-edge technologies help public health professionals detect and respond to infectious disease outbreaks more rapidly and effectively than traditional methods. The Centers for Disease Control and Prevention’s Epidemic Intelligence Service (EIS) officers presented a few of their resources to their colleagues in a special session on May 3, Using Advanced Molecular Tools to Direct Public Health Action, at the 65th Annual EIS Conference in Atlanta, Georgia.
CDC EIS Officers Presented Emerging Vector-borne Disease Research at Recent Conference
May 23rd 2016“Vector-borne diseases are among the most complex of all infectious diseases to prevent and control. Not only is it difficult to predict the habits of mosquitoes, ticks, and fleas, but most vector-borne viruses or bacteria infect animals as well as humans,” according to the Centers for Disease Control and Prevention (CDC).